Skip to content
Research Article Open access CC BY 4.0

The Challenges Facing in Commercial Biotechnology: Its Position in Egypt and Some African Countries

Ali Mohamed Elshafei, Rawia Mansour

Annual Research & Review in Biology · pp. 1–11 · Published 3 Feb 2018

10.9734/ARRB/2018/39258

Abstract

Commercialization of biotechnology can be defined as the conversion of new scientific findings, innovations and discoveries in biotechnology through successful companies and firms or the process by which a product or service in biotechnology is introduced into the general market. Many processes such as sales, production, distribution, marketing, and customer support are required to achieve commercial success. This article deals with factors affecting commercialization of biotechnology in competitive countries and position of biotechnology commercialization in many African countries, including Egypt.

Biotechnology commercialization competitive countries factors affecting Africa Egypt

Cited by 1

Biopreparations for the decomposition of crop residues

Patrycja Rowińska, Beata Gutarowska, Regina Janas · Microbial Biotechnology · 2024

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.